Yanpeng Xu

11PUBLICATIONS
36CO-AUTHORS
NanomedicinePowder and particle technologyInfant and child healthMedical infection agents (incl. prions)Computational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 28, 2025
Recapitulating dengue virus infection with human pluripotent stem cell-derived liver organoids for antiviral screening.

Meng-Qi Li, Yan-Peng Xu, Kai Li

|Aug 21, 2025
Highly scalable prefusion-stabilized RSV F vaccine with enhanced immunogenicity and robust protection.

Qingrui Huang, Qingyun Lang, Yao Li

|Apr 11, 2025
The Changed Endemic Pattern of Respiratory Syncytial Virus Infections in Pediatric Patients With the Relaxation of NPIs in Beijing, China, 2022-2023.

Mingli Jiang, Fengjie Wang, Yanpeng Xu

|Oct 23, 2023
Manganese Mineralization of Pathogenic Viruses as a Universal Vaccine Platform.

Pan-Deng Shi, Yan-Peng Xu, Zhu Zhu

|Dec 16, 2022
Changes in endemic patterns of respiratory syncytial virus infection in pediatric patients under the pressure of nonpharmaceutical interventions for COVID-19 in Beijing, China.

Ming-Li Jiang, Yan-Peng Xu, Hui Wu

|Nov 30, 2021
Identification of oligosaccharyltransferase as a host target for inhibition of SARS-CoV-2 and its variants.

Yi-Jiao Huang, Hui Zhao, Xun Huang

Pageof 2

Frequent Collaborators

7 joint publications

Cheng-Feng Qin

2 joint publications

Yong-Qiang Deng

1 joint publications

Ling Yuan

1 joint publications

Xing-Yao Huang